ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2963

BehçEt’s Disease in Children: Eastern Mediterranean Experience

Hafize Emine Sonmez1, Ezgi Deniz Batu1, Betul Sozeri2, Yonatan Butbul Aviel3, Yelda Bilginer4 and Seza Ozen5, 1Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Pediatric Rheumatology, Erciyes University Faculty of Medicine, Kayseri, Turkey, 3Pediatric Rheumatology, Rambam Medical Center, Haifa, Israel, 4Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, ANKARA, Turkey, 5Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome, Diagnostic criteria, Outcome measures, pediatrics and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Behçet’s disease (BD) is a variable vessel vasculitis which is more common in adults. The most widely used diagnostic criteria for adult onset disease is the International Behçet’s Study Group (ISG) criteria. A new set of criteria for the classification of Behçet’s disease (BD) in children (the pediatric BD [PEDBD] criteria) has been proposed recently. To evaluate the disease activity; there are mainly two severity scores the BD dynamic activity measure (IBDDAM) and BD current activity form (BDCAF). We aimed to test the performance of the PEDBD criteria compared to the ISG criteria and to check the correlation between the severity score systems and physician global assessment (PGA) in pediatric BD patients.

Methods: Two centers from Turkey and one center from Israel participated in this study. The disease onset was ≤16 years of age. As controls, pediatric patients with rheumatologic other diseases.

Results: Sixty-eight BD (44.1% male) patients and 93 control patients were included. The sensitivity and specificity of the PEDBD and the ISG criteria were 73.5%/52.9% and 98.9%/100%, respectively. Thirty-two (47%) patients with BD failed to fulfill the ISG criteria. However, almost all of these patients met the PEDBD criteria. The median (min-max) IBDDAM and BDCAF scores at diagnosis were 6 (1-23) and 4 (1-7) and significantly decreased to 1 (0-8) and 1 (0-4) respectively at latest follow-up (p<0.001 for both). The median (min-max) PGA score at diagnosis was 5 (2-9) and significantly decreased to 1 (0-7) at latest follow-up (p<0.001). IBDDAM had a strong positive correlation with BDCAF (r=0.637; p<0.001). PGA positively correlated with BDCAF and IBDDAM (r=0.502; p<0.001 and r=0.624; p<0.001, respectively).

Conclusion: In our pediatric series, the PEDBD criteria showed better sensitivity than the ISG criteria and the specificities were close. The higher sensitivity is a big advantage for pediatric patients since early diagnosis is very important. Our study also demonstrated that the severity scores were positively correlated with each other and PGA and thus may be used in clinical practice to evaluate children with BD.  


Disclosure: H. E. Sonmez, None; E. D. Batu, None; B. Sozeri, None; Y. Butbul Aviel, None; Y. Bilginer, None; S. Ozen, None.

To cite this abstract in AMA style:

Sonmez HE, Batu ED, Sozeri B, Butbul Aviel Y, Bilginer Y, Ozen S. BehçEt’s Disease in Children: Eastern Mediterranean Experience [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/behcets-disease-in-children-eastern-mediterranean-experience/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/behcets-disease-in-children-eastern-mediterranean-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology